Autoradiograms obtained after middle cere bral artery occlusion (MCAO) in spontaneously hyperten sive rats show that the 99mTc complex of a 2-nitroimid azole-derivatized propylene amine oxime (BMS-181321) is selectively retained in acutely ischemic brain before disruption of the blood-brain barrier (BBB), but not in the ischemic infarct. BMS-181321 is therefore a marker of ischemic tissue at risk of infarction and its uptake, unlike that of x-ray and magnetic resonance contrast agents, does not require disruption of the BBB. In keeping with this conclusion, we have found that the single-pass cere bral extraction fraction of BMS-181321 is 0.67 at normal rat whole-brain blood flow. Sequential single-photon
Delineation of viable ischemic tissue that is a tar get of various intervention strategies represents an important goal of nuclear medicine (Goldstein, 1990; Gropler and Bergman, 1991; Heiss et aI., 1992) . One approach to this problem involves local ization of hypoxic tissue using eSF]fluoromisonida zole and positron emission tomography (Rasey et aI., 1986; Hoffman et aI., 1978; Martin et aI., 1989; Shelton et aI., 1990) . Other approaches involve eSF]fluorodeoxyglucose (Brunken et aI., 1986; , 2 0lTl (Schwartz, 1990) , and s 2 Rb (Gould, 1991) . Misonidazole is a 2-nitroimid azole (2NI) derivative that is selectively retained in emission computed tomographic images obtained from cats after MCAO show that the initial distribution of BMS-181321 approximates regional CBF and that selec tive retention subsequently produces a positive image within the ischemic territory. BMS-181321 is the first Tc complex able to indicate not only ischemia, but also isch emic tissue at risk of infarction. Use of this novel Tc complex to monitor biochemical events during ischemia may contribute to the clinical management of acute stroke. Key Words: Hypoxia-Ischemia-Misonid azole-Neuronal viability-Single-photon emission com puted tomography. hypoxic tissue. Studies of e4C]misonidazole bind ing to V -79 hamster cells show that increased bind ing occurs below oxygen concentrations of 2 flM or 1.4 mm Hg (Koch et aI., 1984) . Radiosensitization has also been observed after administration of miso nidazole. The half-maximal radiosensitizing effect of misonidazole is at -400 ppm or -0.32 mm Hg of oxygen (Roizen-Towle et a\., 1986) . Selective reten tion in hypoxic tissue involves reduction of the nitro group by cellular reductases and diminished reoxi dation by oxygen, which is followed by further re duction and binding to cellulat: components (Mason and Holtzman, 1975; Chapman et a\., 1983) .
The finding of selective retention in ischemic dog myocardium, when eSF]fluoromisonidazole is in jected soon after the onset of ischemia, and the ab sence of retention, when eSF]fluoromisonidazole is injected 24 h later, suggests that this agent is re tained only in viable hypoxic cells (Shelton et aI., 1990) . Unfortunately, the utility of eSF]fluoromi sonidazole as an imaging agent for hypoxic tissue is limited by the availability of the necessary positron emission tomography instrumentation. In addition, imaging of hypoxic tissue during stroke would be enhanced by development of an agent with a greater ability to traverse the blood-brain barrier (BBB). In an in vivo model, the brain capillary permeability coefficient P for misonidazole was only 5% of the corresponding value for water (Levin, 1980) . A sim ilar permeability coefficient for fluoromisonidazole is likely, since the octanollwater partition coeffi cient of misonidazole is 0.41 and that of fluoromi sonidazole is 0.40 (Grunbaum et aI., 1987) . A 99mTc_ labeled 2NI that localizes in hypoxic tissue and has a greater BBB permeability than [18F]fluoromi sonidazole would allow imaging of hypoxic tissue to be performed more readily using single-photon emission computed tomography (SPECT). More over, the initial distribution of a 99mTc-Iabeled 2NI with a high BBB permeability might be expected to approximate regional CBF (rCBF). A 2NI derivatized propylene amine oxime (PnAO) ligand and its 99mTc complex, which has the necessary properties, have been synthesized for this purpose.
The structure of the complex, 99mTcO(PnAO)-I-(1-2NI) (BMS-181321), is shown in Fig. 1 . In the present article, we present autoradiographic and SPECT images of focal cerebral ischemia, which demonstrate that the distribution of BMS-181321 initially approximates rCBF, whereas selective re tention subsequently produces a positive image of ischemic tissue at risk of infarction.
METHODS

Spontaneously hypertensive rat middle cerebral artery occlusion
We used a spontaneously hypertensive rat (SHR) mid dle cerebral artery occlusion (MCAO) model (Brint et aI., 1988) to demonstrate the relationship between rCBF and FIG. 1. The structure of BMS-181321. This transition metal complex has a square pyramidal coordination geometry. with an oxygen atom at the apex of the pyramid and the four nitrogen atoms of the propylene amine oxime (PnAO) ligand at the base. On complexation. a hydrogen bond is formed between the two oximes. giving the molecule a stable mac rocyclic structure. The nitroimidazole is attached to the PnAO core at the 1-position.
J Cereb Blood Flow Metab. Vol. 13. No.5, 1993 brain retention of BMS-181321. Unfasted male SHRs weighing between 320 and 400 g were anesthetized with 5% halothane. Surgical anesthesia was maintained using halothane concentrations between 1.0 and 2.5%. For rats tested 1 h after MCAO (n = 3), the femoral artery and vein were catheterized and Evans Blue (EB) dye (Wol man et aI., 1981) was injected intravenously (2 ml/kg, 2% solution in saline). Craniectomy was performed with a 3-mm trephine to expose the MCA, which was occluded by electrocautery in tandem with ligation of the ipsilateral common carotid artery. Rats were allowed to recover from anesthesia before reanesthetization and intravenous injection of BMS-181321 (30-35 mCi) . It was therefore necessary to wrap them in plaster casts to eliminate ac cess to the catheters. We found that these rats struggled less against the restraint when they were placed in sus pending hammocks during the recovery period. For rats tested 24 h after MCAO (n = 3), EB was injected by venipuncture and MCAO was performed as described above. Rats were then returned to home cages, where food and water were available ad libitum, and catheter ized after reanesthetization. At the 24-h test time, rats were reanesthetized and venous and arterial catheters were implanted as described above. For all rats, light anesthesia was maintained at the time of testing using 0.5-1.0% halothane. BMS-181321 (30-35 mCi; see below) was injected intravenously 1 or 24 h after MCAO. rCBF was determined using [14C]iodoantipyrine ([14C]lAP; Du Pont, NEN Research Products) in an indicator fraction ation procedure 30 min after administration of BMS-181321 (Van Uitert and Levy, 1978; Brint et aI., 1988) . We injected [14C]IAP (30 jJ-Ci in 0.3 ml saline) through the femoral venous catheter, while collecting arterial blood at a known rate (1.1 mllmin). Anesthetized rats were decap itated 8 s after the start of the injection, and blood col lection was stopped simultaneously by a switch activated by the guillotine. Brains were rapidly removed and frozen in liquid Freon-22. Twenty-micron sections were cut on a freezing microtome, picked up onto cold glass slides, and dried on a slide warmer at 60°C. Arterial14C radioactivity was determined by counting an aliquot of dissolved (Solv able; NEN Du Pont) blood in a liquid scintillation counter (Beckman model LS 7500).
Double-label autoradiography
Double-label 99mTc/14c autoradiography provided sep arate images of the microregional distribution of BMS-181321 and rCBF in the same tissue sections. Kodak XAR x-ray film was exposed to the dried tissue sections in x-ray cassettes overnight, with extra-heavy-duty alu minum foil interposed between the film and tissue to block totally radioactivity emanating from 14C, while al lowing penetration by conversion electrons emanating from 99mTc. This was verified using 14C microscale stan dard strips (40 to 1069 nCi/g; Amersham) placed next to the sections. Thus, the first overnight exposure repre sented a pure image of the microregional distribution pat tern of BMS-181321. After 72 h to allow for decay of the 99mTc (142 kEv, 6.5-h half-life), a second exposure of Kodak XAR-5 film was made to the tissue and calibrated 14C microscale standard strips (Amersham) for 5-7 days without the aluminum foil.
Computer-enhanced image analysis
Imaging Research's Ml image analysis software was used to digitize and analyze the autoradiographic and his-tological images. This software was used in conjunction with an Imaging Technologies FG-100-AT digitizing card, which was installed in an AT-compatible 386/25-mHz computer, coupled to a Sierra Scientific high-resolution CCD camera fitted with a Nikon 55 mm f/2.8 macro lens and an Electrohome high-resolution monitor. Before dig itizing the autoradiograms, a blank view of the precision light box (Northern Light, model 890) was digitized to establish corrections for shading errors. All autoradio grams were digitized, corrected for shading error, and then saved. The 99mTc autoradiograms were digitized in spatial registration with corresponding 14C autoradio grams to justify region-of-interest (ROn transfer between images. 99mTc and 14C autoradiograms of the same sec tion were loaded into separate memory frames using the same area calibrations. In subsequent analyses, relative optical density (ROD), which is linear with respect to radioactivity emanating from 14C standards over the range of tissue 99mTc activity, was calculated from light transmittances (gray levels) according to ROD = 10g lO (256/level), since the scale of image light transmittance can be divided into 256 arbitrary gray levels. Background ROD was subtracted from the ROD of all tissue ROIs. We delimited the edge of the ROI, on the 99mTc autoradio gram, containing pixel RODs? 1.96 SDs greater than the average ROD for the nonischemic hemisphere after back ground subtraction. This region was defined as the ROI for increased selective retention of BMS-181321. The ROD ratio of this ROI relative to the nonischemic hemi sphere was determined. The lines defining this ROI were transferred to the 14C autoradiogram and the rCBF ratio of this ROI relative to the nonischemic hemisphere was determined using brain and blood 14C radioactivity (Van Uitert and Levy, 1978) . Brain ROI 14C concentration per gram of tissue was determined from the standard curve relating optical density to 14C microcuries per gram. The standards are calibrated for 20-lLm sections. The relative retention of BMS-181321 as a function of rCBF for pixels traversing the edge of the ischemic territory was then determined. Straight lines were drawn through the edge of the ischemic territory. Relative retention of BMS-181321 was defined, for pixels in these lines, as the ROD of a line pixel on the BMS-181321 autoradiogram divided by the average ROD of the nonischemic hemisphere in the same autoradiogram. These values were then plotted as a function of pixel rCBF.
Fluorescence micrography and histology
After the autoradiograms were digitized and analyzed, the tissue sections were illuminated under green light and photomicrographs of EB fluorescence were obtained us ing Tmax 100 Kodak film, an Olympus 35-mm camera, and an inverted fluorescence microscope. Photographic negatives were transilluminated on the precision light box. Resultant negative images were then digitized and saved using the image analysis software. After comple tion of fluorescence micrography, the dried tissue sec tions were stained with cresyl violet to provide histolog ical material that would reveal the presence of infarction.
SPECT
To evaluate the hypothesis that the early distribution of BMS-181321 approximates rCBF and demonstrate the feasibility of external imaging, sequential SPECT images were obtained from cats (n = 4) after intravenous injec-tion of BMS-181321 (30-50 mCi) 1 h after occlusion of the proximal MCA (O'Brien and Waltz, 1973) . Studies were conducted with an Elscint Apex model 409 SPECT gamma camera system using a low-energy, high resolution parallel-hole collimator. One hundred twenty frames (128 x 128 pixels each) were acquired during each camera rotation of 3600• The first image was acquired between 2 and 8 min after injection, while the second SPECT image was acquired between 144 and 156 min after injection. The shorter initial acquisition was de signed to take advantage of the initial flow distribution, while the longer subsequent acquisition was designed to maximize acquired counts from diminished tissue con centrations of the agent. After the final acquisition, brains were removed, 40-lLm sections were cut, and autoradio grams were prepared as described above. A Hanning fil ter was used for the 2-pixel-thick transaxial reconstruc tions, which were then used to reconstruct transverse (horizontal) sections. For presentation purposes, the SPECT images were sized to accommodate the brain out line obtained from the autoradiogram.
Rat single-pass cerebral extraction
We used an indicator fractionation method that re quires the intracardial administration of a mixture of ra diolabeled micro spheres and test substance for the simul taneous determination of single-pass extraction (E) and CBF (Irwin and Preskorn, 1982; Di Rocco et aI., 1992b) . Normotensive Sprague-Dawley rats were anesthetized with Nembutal (50 mg/kg), tracheotomized, thoracoto mized, and artificially ventilated to maintain normal blood gas values. Next, with the reference organ arterial blood withdrawal pump turned on, the injection mixture of BMS-181321 and 85Sr-Iabeled polystyrene micro spheres (16.1 ± 0.1 ILm; Dupont-NEN) was rapidly «0.5 s) injected into the left ventricle. Six seconds after injec tion, the rat was decapitated and simultaneously the sy ringe pump was stopped by a switch triggered by the guillotine. The brain was removed within 3-4 min of de capitation and weighed. 99mTc and 85Sr activities in the whole brain and arterial blood were measured with an LKB 1282 Commpugamma gamma counter, which cor rected for crossover counts for each radionuclide. These values were used to calculate E and CBF as previously described (Irwin and Preskorn, 1982; Di Rocco et aI., 1992b) .
Radiopharmaceutical preparation
BMS-181321 was prepared by reconstituting the freeze dried ligand with 1.0-3.0 ml of a normal saline/generator eluant mixture containing 30-100 mCi of 99mTc0 4 -. The reaction was initiated by adding 50 ILl of saturated Sn tartrate solution to the above with a Hamilton syringe. The vial was shaken and allowed to stand at room tem perature for 10 min. The complex was then either sepa rated from nonradioactive kit components by adsorption onto PRP-l reversed phase resin or used directly after determination of radiochemical purity. In the former case, the product was eluted from the resin with 1 ml of 100% ethanol, which was removed by evaporation under a stream of nitrogen. The complex was then dissolved in normal saline to the desired concentration (25-60 mCi/ mI). All injected material was characterized by high pressure liquid chromatography on a 10-lLm Hamilton PRP-l column eluted with 65:35 acetonitrile/O.l M A FIG. 2. Autoradiograms and histological sections showing that BMS-181321 is selectively retained in acutely ischemic brain, but not the ischemic infarct. All material is shown in horizontal section. For abbreviations see the text. A: C4C]IAP autoradiogram showing rCBF and the ischemic territory 1 h after MCAD. B: Corresponding 99mTc autoradiogram demonstrating regional selective retention of BMS-181321 at the lateral border of the ischemic territory shown in A. C: Cresyl violet cell stain of the tissue section used to produce the autoradiograms shown in A and B. This section shows that no infarct was present 1 h after MCAD. D: C4C]IAP autoradiogram showing rCBF and the ischemic territory 24 h after MCAD. E: Corresponding 99mTc autoradiogram showing no selective retention of BMS-181321 in the ischemic territory delineated in D. F: Cresyl violet cell stain of the tissue section used to produce the autoradiograms shown in D and E. The histological material shown clearly demonstrates the presence of an infarct 24 h after MCAD. NH 4 0Ac (pH 4.6) at a flow rate of 2 mllmin. Radiochem ical purities of �92% were obtained for all injected ma terial.
RESULTS
Physiological parameters for lightly anesthetized rats just before the administration of BMS-181321 were (mean ± SD, n = 6) 170 ± 19 mm Hg (mean arterial blood pressure), 7.382 ± 0.054 mm Hg (ar terial pH), 45.1 ± 2.6 mm Hg (Paco2, and 108.7 ± 12.7 mm Hg (Pao2) . Blood gas values were normal except for a slight apparent elevation of P aco2, which has been shown to be related to the halothane anesthesia (Brint et al., 1988) .
Representative auto radiograms obtained 1 h after MCAO presented in Fig. 2A and B show that BMS-181321 is selectively retained in the ischemic terri tory of the MCA before the onset of infarction, as shown in Fig. 2C . The ROD ratio for the ischemic ROI demarcated by BMS-181321 relative to the nonischemic hemisphere averaged 6.4 ± 2.2 for the three rats tested 1 h after MCAO. The correspond ing rCBF ratio was 0.08 ± 0.07. Selective retention of BMS-181321 therefore required a reduction of rCBF to �8% of its normal value. In keeping with this observation, the graph shown in Fig. 3 for the three rats tested 1 h after MCAO reveals that selec tive retention of BMS-181321 increased as rCBF of pixels traversing the edge of the ischemic territory declined below 50 ml 100 g-I min-I. Taken to gether, these data show clearly that selective reten tion of BMS-181321 is strictly a function of rCBF and, implicitly, tissue P a02' Accordingly, BMS-181321 will be retained in any region where tissue P a02 is low enough to effect trapping and where rCBF is high enough to permit delivery. The auto-FIG. 3. The ratio of ischemic to nonisch emic BMS-181321 relative optical density (ROD) obtained from each of three rats, indicated by the filled squares, open tri angles, and X's, 1 hour after middle cere bral artery occlusion, plotted as a func tion of regional CBF (rCBF) for pixels along lines traversing the edge of the ischemic territory, as shown in Fig. 2A . Fluorescence micrographs of the EB-albumin complex from ischemic and nonischemic hemi spheres 1 and 24 h after MCAO are shown in Fig. 4 and illustrate that the BBB remained intact at 1 h, but was disrupted by 24 h. The EB-albumin com plex was confined to the vasculature in both hemi spheres 1 h after occlusion, but had extravasated by 24 h, as shown by the fluorescence in parenchyma and reactive astrocytes in the infarct. These obser vations suggest that the selective retention of BMS-181321 is not dependent on the status of the BBB, implying that the BBB is highly permeable to BMS-181321. Further support for a high BBB permeabil ity to BMS-181321 derives from the whole-brain single-pass cerebral extraction experiment, which determined a value of 0.67 ± 0.18 at an average whole-brain blood flow of 42 ± 11 ml 100 g -I min-I (n = 5).
Representative SPECT images are shown in Fig.   5 . The first SPECT image (Fig. 5A) shows that the early regional distribution of this agent approxi mates rCBF. The brain outline was obtained from the autoradiogram shown in Fig. 5C . The ischemic territory is clearly evident in relation to surrounding nonischemic brain. The second SPECT image and brain outline (Fig. 5B) show that BMS-181321 re tention is enhanced in the ischemic brain region shown in Fig. 5A . The autoradiogram obtained after death is presented in Fig. 5C and shows Images obtained from nonischemic and ischemic hemispheres, respectively, of a rat tested 1 h after MeAO. Note that most of the fluorescence is contained within microvessels or arteries, as shown in B, where a penetrating artery can be seen originating from a pial artery at the cortical surface. C and 0: Images obtained from non infarcted and infarcted hemispheres, respectively, of a rat tested 24 h after MeAO. Note that whereas the fluorescence signal is still contained within the microvasculature in the non infarcted hemisphere, the EB-albumin complex has extravasated in the infarcted hemisphere where the fluorescence signal arises from the tissue parenchyma and numerous dark foci resembling astrocytes. E: Fluorescence micrograph, showing the edge of a 24-h infarct demarcating brain regions of high parenchymal/astrocytic and high microvascular fluorescence. F: Fluorescence micrograph showing that the shape of the numerous dark foci within infarcts shown in 0 and E resembles the morphology of reactive astrocytes. The intracellular fluorescence indicates phagocytosis of extravasated EB-albumin complex by the astrocytes.
the core of the ischemic territory as well as the border zone. This pattern was also observed in some rats and is consistent with reports of rCBF reductions of 90-95% in the central MCA territory 1 h after MCAO (Tanaka et aI., 1985) . These obser vations again call attention to the graph shown in Outline of brain autoradiogram shown in C superimposed upon the initial SPEeT image acquired between 2 and 8 min after injection. The ischemic territory is clearly delineated relative to nonischemic surrounding tissue. B: Outline of brain autoradiogram superimposed upon the SPEeT image acquired between 144 and 156 min after injection. Selective retention of BMS-181321 is evident in the ischemic region depicted in A. C: Brain autoradiogram obtained after death, which was used to generate the outline shown in A and B. The autoradiogram shows that BMS-181321 was selectively retained throughout the ischemic territory of the middle cerebral artery. Recent studies have shown that the flow thresh old for infarction in the SHR MCAO model is �50 ml 100 g -1 min -1 for ischemic intervals > 3 h (Jacewicz et aI., 1992) . The CBF threshold for in farction approximates one-third of normal cortical rCBF in the SHR and primates (Brint et aI., 1988; Jascewicz et aI., 1992) . We found that the average rCBF in the region demarcated by BMS-181321 was 8% of normal. These observations suggest that part of the presumptive infarct at the lateral border of the ischemic territory may not be selectively la beled by BMS-181321. This is supported by the data in Fig. 3 , which show the existence of ischemic pix els that have normal levels of BMS-181321 reten tion. These results are consistent with previous studies showing that there is a requirement for ex treme hypoxia to produce a change in the kinetics of misonidazole binding to V -79 hamster cells (Koch et aI., 1984) . It appears likely, therefore, that selec tive retention of BMS-181321 indicates tissue at risk of imminent infarction.
The outward diffusion of vasoconstrictors such as thromboxane A 2 from the core of the ischemic territory has been implicated in infarct progression in stroke (Welch et aI., 1973; Dietrich et aI., 1986) .
Moreover, as previously observed (Heiss et aI., 1992) , current treatment modalities are unable to prevent the evolution of the resultant metabolic de rangement in the periinfarct zone from progressing to necrosis. On the other hand, repeat multitracer positron emission tomography studies in humans show that tissue in the border zone of the ischemic territory remains viable for up to 48 h after stroke (Heiss et aI., 1992) . Accordingly, the fate of the periinfarct zone remains a focus of strategies for neuroprotection and reperfusion in stroke. The abil ity to acquire an initial image of ischemia and a subsequent image indicating ischemic tissue at risk of infarction, after a single injection of BMS-181321, may have a significant impact on the man agement of acute stroke.
